Research
April 3, 2024
Three UAMS Research Teams Named Inaugural Recipients of BioVentures Accelerator Awards
BioVentures LLC at UAMS recently announced the selection of three UAMS research teams as the inaugural recipients of its new AR Health Ventures Accelerator (ARHVA) program. The accelerator program, which aims to help jump-start the translation of promising scientific discoveries into therapies, is providing the selected projects with substantial benefits, including financial grants up to…
March 20, 2024
UAMS Students Shine in Student Research Day Presentations
Graduate and professional students, postdoctorate fellows, and medical house staff presented research to faculty and peers during Student Research Day at the University of Arkansas for Medical Sciences (UAMS). Nobel Prize winner Craig C. Mello, Ph.D., spoke as part of the Robert E. McGehee Jr., Ph.D., Distinguished Lectureship in Biomedical Research. A concurrent Student Research…
February 6, 2024
UAMS Research Team Discovers Potential Alzheimer’s Drug
LITTLE ROCK — A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D. The findings were published Jan. 8 in Communications Biology and include discoveries of a druggable target and a…
January 30, 2024
Teenage Researcher Leads UAMS Parkinson’s Study Published in Scientific Reports
LITTLE ROCK — Eighteen-year-old Anu Iyer, the recent Little Rock Central High School graduate and machine-learning sensation collaborating with a University of Arkansas for Medical Sciences (UAMS) research team, is the lead author on a publication in Scientific Reports, part of the Nature portfolio journals. She was joined as co-first author by UAMS’ Aaron Kemp,…
January 19, 2024
Arkansan Sees Advanced Cancer Disappear with Experimental Drug Offered at UAMS Winthrop P. Rockefeller Cancer Institute
A Little Rock man with resistant kidney cancer who underwent experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has experienced a complete remission.
November 15, 2023
NIH Awards UAMS $1.54 Million to Tackle Brittle Bone Disease
LITTLE ROCK — A UAMS research team is using a $1.54 million grant from the National Institutes of Health (NIH) to support its goal of finding better treatments for osteogenesis imperfecta (OI), also known as brittle bone disease. The four-year award from the NIH National Heart, Lung, and Blood Institute will allow Roy Morello, Ph.D.,…
November 6, 2023
UAMS BioVentures Awarded Nearly $3 Million for Health Tech Entrepreneurship Program, Invited to White House
LITTLE ROCK — BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS) has secured a nearly $3 million grant from the U.S. Department of Commerce to support entrepreneurs from socially and economically disadvantaged backgrounds who are looking to develop health technology and health care businesses in Arkansas. The four-year $2,999,997 grant comes from…
October 20, 2023
Investigators Soak in Research Expo 2023’s Abundant Resources, Services
Alberto Ramirez, Ph.D., was excited to attend Research Expo 2023, with its 50 research services and resources on display. “As an early-career researcher, the event proved to be remarkably valuable as it allowed me to gain insight into the numerous resources offered by UAMS, including TRI, Research & Innovation, and more, which have the potential…
October 3, 2023
NIH Awards UAMS $606,274 to Research Cardiovascular Risks Associated with Kidney Disease
LITTLE ROCK — A team of three researchers at the University of Arkansas for Medical Sciences (UAMS) will use a recent $606,274 grant to investigate how the body’s natural defense mechanisms contribute to cardiovascular risks for patients with kidney disease. The one-year grant is an administrative supplement to the Arkansas IDeA Network for Biomedical Research…
September 5, 2023
National Cancer Institute Awards UAMS Researcher $1.8 Million to Study Prevention of Major Chemotherapy Complications
LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researcher Amanda Stolarz, Pharm.D., Ph.D., recently received a five-year, $1.8 million grant from the National Cancer Institute (NCI) at the National Institutes of Health (NIH). Stolarz, an assistant professor of pharmaceutical sciences in the UAMS College of Pharmacy, is the principal investigator on a study…
Previous page Next page